<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Thymol (2-isopropyl-5-methylphenol) was evaluated in two different models, inflammation in aortic intimal and imiquimod-induced psoriasis. In the first model, the antioxidant tests were evaluated 
 <italic class="italic">in vitro</italic> DPPH and ABTS radical scavenging assay, demonstrating high antioxidant activity. The treatment also reduced lipid peroxidation 
 <italic class="italic">in vivo</italic>, reducing serum levels of malondialdehyde. In relation to the parameters of anti-inflammatory activity, thymol reduced the expression of vascular adhesion molecules (VCAM), thus reducing leukocyte migration and proinflammatory cytokines [
 <xref rid="B45" ref-type="bibr" class="xref">45</xref>]. Thus, the results suggest that this monoterpene reduced the oxidative stress, the putative mechanism involved in the pathogenesis of endothelial dysfunction, an early key event in the progression of atherosclerosis [
 <xref rid="B95" ref-type="bibr" class="xref">95</xref>].
</p>
